Top

Published in:

01-03-2005 | Original Article

Long-term use of recombinant human growth hormone in pediatric allograft recipients: a report of the NAPRTCS Transplant Registry

Authors: Richard N. Fine, Donald Stablein

Published in: Pediatric Nephrology | Issue 3/2005

Abstract

Data from the NAPRTCS database were analyzed for growth, allograft function, and targeted adverse events (AE) over a 5-year period in 513 recipients who received recombinant human growth hormone (rhGH) treatment and compared with the outcome of 2,263 concurrent controls who did not receive rhGH. Recipients less than 10 years of age grew better than older recipients. Final adult height was superior in the rhGH-treated group compared with the control group. Allograft function and graft failure rate was similar in the rhGH-treated and control groups. No increased incidence of AE was noted in the rhGH-treated group. rhGH is effective and safe for use in growth-retarded pediatric renal allograft recipients.

Mehls O, Ritz E (1983) Skeletal growth in experimental uremia. Kidney Int 24:53–62

Fine RN, Sullivan EK, Tejani A (2000) The impact of recombinant human growth hormone treatment on final adult height. Pediatr Nephrol 1–3

McEnery PT, Alexander SR, Sullivan K, et al (1993) Renal transplantation in children and adolescents: the 1992 Annual Report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Nephrol 7:711–720

Feld LG, Stablein DM, Fivush BA, et al (1997) Renal transplantation in children from 1987–1996: The Annual Report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Transplant 1:146–162

Benfield MR, McDonald R, Sullivan EK, et al (1999) The 1997 Annual Renal Transplantation in Children: Report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Transplant 2:152–167

Koch VAH, Lippe BM, Nelson PA, Boechat MI, Sherman BM, Fine RN (1989) Accelerated growth after recombinant human growth hormone treatment of children with chronic renal failure. J Pediatr 115:365–371PubMed

Tejani A, Fine RN, Alexander S, et al (1993) Factors predictive of sustained growth in children after renal transplantation. J Pediatr 122:397–402

Tyden G, Berg U, Reinholt F (1990) Acute renal allograft rejection after treatment with human growth hormone. Lancet 336:1455–1456

Schwartz D, Warady BA (1992) Cadaveric renal allograft rejection after treatment with recombinant human growth hormone. J Pediatr 121:664–665

10.

Rees L, Rigden SPA, Ward G, Preece MA (1990) Treatment of short stature in renal disease with recombinant human growth hormone. Arch Dis Child 65:856–860

11.

Johansson G, Sietnieks A, Janssens F, et al (1990) Recombinant human growth hormone treatment in short children with chronic renal disease, before transplantation or with functioning renal transplants: an interim report on five European studies. Acta Paediatr Scand [Suppl 370]:36–42

12.

Tonshoff B, Dietz M, Haffner D, et al (1991) Effects of two years of growth hormone treatment in short children with renal disease. Acta Paediatr Scand [Suppl] 379:33–41

13.

Fine R, Yadin O, Nelson PA, et al (1991) Recombinant human growth hormone treatment of children following renal transplantation. Pediatr Nephrol 5:47–151

14.

Fine RN, Yadin O, Moulten L, et al (1992) Extended recombinant human growth hormone treatment after renal transplantation in children. J Am Soc Nephrol 2 [Suppl]:S274–S283

15.

Bartosh S, Kaiser B, Rezvani I, et al (1992) Effects of growth hormone administration in pediatric renal allograft recipients. Pediatr Nephrol 6:68–73

16.

Van Dop D, Jabs KL, Donohoue PA, et al (1992) Accelerated growth rates in children treated with growth hormone after renal transplantation. J Pediatr 120:244–250

17.

Jabs K, Van Dop C, Harmon W (1993) Growth hormone treatment of growth failure among children with renal transplants. Kidney Int 44 [Suppl 43]:S71–S75

18.

Janssen F, Van Damme-Lombaerts R, Van Dyck M, et al (1993) Effects of recombinant human growth hormone on graft function in renal-transplanted children and adolescents: the three-year experience of a Belgian Study group. Transplant Proc 25:1049–1050

19.

Tonshoff B, Haffner, D, Mehls O, et al (1993) Efficacy and safety of growth hormone treatment in short children with renal allografts: three year experience. Kidney Int 44:199–207

20.

Benfield MR, Parker KL, Waldo FB, et al (1993) Treatment of growth failure in children after renal transplantation. Transplantation 55:305–308

21.

Hokken-Koelega ACS, Stijnene T, De Ridder MAJ, et al (1994) Growth hormone treatment in growth-retarded adolescents after renal transplant. Lancet 343:1313–1317

22.

Chavers BM, Doherty L, Nevins TE, et al (1996) Effects of growth hormone treatment. Transplantation 61:893–903

23.

Maxwell H, Dalton RN, Nair DR, et al (1996) Effects of recombinant human growth hormone on renal function in children with renal transplants. Pediatrics 128:177–183

24.

Laine J, Krogerus L, Sarna S, et al (1996) Recombinant human growth hormone treatment. Transplantation 61:893–903

25.

Janssen F, Van Damme-Lombaerts R, Van Dyck M, et al (1997) Impact of growth hormone treatment on a Belgian population of short children with renal allografts. Pediatr Transplant 1:190–196

26.

Wuhl E, Haffner D, Tonshoff B, Mehls O (1993) The German Study Group for Growth Hormone Treatment in Chronic Renal Failure. Predictors of growth response to rhGH in short children before and after renal transplantation. Kidney Int 44 [Suppl 43]:S76–S82

27.

Hokken-Koelega ACS, StijnenT, De Jong MCJW, et al (1996) A placebo-controlled double-blind trial of growth hormone treatment in prepubertal children with renal allografts. Kidney Int 49 [Suppl 53]:S126–S127

28.

Maxwell H, Rees L (1998) Randomised controlled trial of recombinant human growth hormone in prepubertal and pubertal renal transplant recipients. Arch Dis Child 79:481–487

29.

Guest G, Berard E, Crosnier H, et al (1998) Effects of growth hormone in short children after renal transplantation. Pediatr Nephrol 12:437–446CrossRef

30.

Fine RN, Stablein D, Cohen A, Tejani A, Kohaut E (2002) Recombinant human growth hormone post-renal transplantation in children: a randomized controlled study of the NAPRTCS. Kidney Int 62:688–696CrossRef

31.

Morel P, Almond PS, Matas AJ, et al (1991) Long-term quality of life after kidney transplantation in childhood. Transplantation 52:47–52

32.

Tyden G, Wernersson A, Sandberg J, Berg U (2000) Development of renal cell carcinoma in living donor kidney grafts. Transplantation 70:1650–1656

33.

Mehls O, Wilton P, Lilien M, Berg U, et al (2002) Does growth hormone treatment affect the risk of post-transplant renal cancer? Pediatr Nephrol 17:984–989

Title: Long-term use of recombinant human growth hormone in pediatric allograft recipients: a report of the NAPRTCS Transplant Registry
Authors: Richard N. Fine
Donald Stablein
Publication date: 01-03-2005
Publisher: Springer-Verlag
Published in: Pediatric Nephrology / Issue 3/2005
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI: https://doi.org/10.1007/s00467-004-1688-5

At a glance: The STEP trials

Springer Medicine

Long-term use of recombinant human growth hormone in pediatric allograft recipients: a report of the NAPRTCS Transplant Registry

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2005

Pathogenesis of parathyroid dysfunction in end-stage kidney disease

The multi-functional role of insulin-like growth factor binding proteins in bone

Allelic differences in a quantitative trait locus affecting insulin-like growth factor-I impact skeletal acquisition and body composition

The therapeutic potential of novel phosphate binders

Alterations of the growth plate in chronic renal failure

The growth hormone-insulin like growth factor axis revisited: lessons from IGF-1 and IGF-1 receptor gene targeting